UK Medical Device Pathway Watch: September 2025

The UK medical device framework continues to require careful route planning. Manufacturers should treat market access as a controlled programme covering registration, economic operator responsibilities, conformity assessment, and product life-cycle evidence.

What to review

• The intended Great Britain route and the status of applicable conformity documentation.
• Registration data, manufacturer details, and the responsible person role where required.
• Labelling, vigilance, field safety corrective action, and post-market surveillance procedures.

Practical impact

Product portfolios often follow different routes depending on device type, certificate status, and intended launch timeline. A product-by-product plan is more reliable than a single company-wide assumption.

Source to monitor

Use the MHRA guidance for regulating medical devices as the primary source for current UK requirements.